Home Search
dendritic cells cancer - search results
If you're not happy with the results, please do another search
T cells play an important role in immune response, according to new research
A research team from Germany has found that T cells play a pivotal role in the body’s immune response to viral infections.
There are 600...
Defence’s ACCUMTM variant “A1” converts mesenchymal stromal cells into potent antigen presenting cells
Defence Therapeutics has announced groundbreaking news about the development of a novel anti-cancer cellular vaccine using reprogrammed mesenchymal stromal cells.
Defence Therapeutics Inc., a Canadian...
New mRNA cancer vaccine eliminates tumours
A new mRNA-based cancer vaccine shows potential in eliminating tumours and preventing recurrence in mice.
Cancer vaccines are a controversial topic with plenty of research...
Defence Therapeutics’ technology optimises cancer vaccine efficacy
Biotechnology experts Defence Therapeutics are leading the fight against cancer and infectious diseases. Discover how their revolutionary drug enhancer platform is elevating cancer vaccine...
Enhancing the efficacy of cancer vaccines and antibody drug conjugates
In its quest to optimise treatment for cancer and infectious diseases, Defence Therapeutics illustrates how its groundbreaking Accum technology elevates the performance of vaccines...
Towards a cancer revolution with new targeted therapeutics
Defence Therapeutics Inc’s proprietary new platform offers a revolution in drug delivery.
Quebec-based biotechnology developer Defence Therapeutics Inc specialises in antibody-drug conjugates (ADCs), a novel...
Cancer vaccine shows long-lasting anti-tumoural response
A pre-clinical study has demonstrated the anti-tumoural efficacy of the AccuVAC-D001 cancer vaccine.
Developed by biotechnology company Defence Therapeutics Inc., the AccuVAC-D001 cancer vaccine demonstrated...
Synthetic cells reveal how the immune system communicates
Three-dimensional synthetic cells have revealed the hidden messages of the immune system.
Research led by Professor Mike Dustin's group of the Kennedy Institute of Rheumatology...
First of its kind AST-VAC2 vaccine gets tested to treat lung cancer
In a collaboration agreement between Cancer Research UK (CRUK) and Asterias, a first of its kind vaccine, AST-VAC2, has entered into a phase I...
COVID-19 can slow down innate immune system recovery
According to researchers from Linköping University, the severity of COVID-19 infections is directly related to the slower recovery of the innate immune system.
COVID-19 infection...
Researchers identify origins of Langerhans cell histiocytosis in children
The origins of Langerhans cell histiocytosis have been identified by researchers from Karolinska Institutet in collaboration with Karolinska University Hospital.
Langerhans cell histiocytosis is a...
Enhancing treatment efficacy and antigen delivery with Accum
Defence Therapeutics outlines the potential of their innovative AccumTM technology to improve intracellular antigen delivery and ultimately enhance treatments for cancer and infectious diseases.
Defence...
New universal influenza B vaccine offers extensive protection
A new universal influenza B vaccine offers a strong defence against different strains and improved immune protection.
A new study by biomedical scientists from the Institute...
New study discovers a promising mushroom extract that clears HPV infection
Research by the University of Texas has found a mushroom extract that supports the immune system in clearing HPV infections.
The mushroom extract, known as...
Defence Therapeutics: changing the face of vaccines using AccumTM technology
Biotechnology specialists Defence Therapeutics are changing the face of vaccines using its AccumTM technology to enable precise delivery of proteins of pharmacological interest to...
Drug enhances bone marrow transplant outcomes for leukaemia patients
Experts have identified a drug that reduces the risk of leukaemia recurring when administered in combination with a bone marrow transplant.
A team of researchers...
Versatile Accum technology for various immune-oncology needs
Defence Therapeutics explains how its Accum™ technology can enhance the delivery of tumour and infectious disease-specific therapeutics.
The principal technology developed by Defence Therapeutics (DT)...
Defence Therapeutics: Transforming drug delivery and improving treatment
Defence Therapeutics is continuously expanding on its portfolio of solutions to enhance drug delivery and improve treatment outcomes for patients with cancer and infectious...
Study demonstrates long-lasting efficacy of COVID-19 vaccine programme
Researchers carrying out pre-clinical testing of a COVID-19 vaccine programme have discovered a high antibody response, lasting over 18 weeks.
Biotechnology company Defence Therapeutics Inc...
Using microneedles for painless drug delivery
Researchers have suggested using microneedles for immunotherapy to vaccinate or treat diseases such as cancer and autoimmune disorders, with minimal pain, invasiveness, and side...
